Cellectis Cash from Other Financing Activities (Quarterly) Analysis

Cellectis SA (CLLS)

3.98 +0.08 (+2.05%) USD | NASDAQ | Feb 23, 10:01

View Cash from Other Financing Activities (Quarterly) for CLLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cash from Other Financing Activities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Cash from Other Financing Activities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Cash from Other Financing Activities (Quarterly) Benchmarks

Start Trial

EDAP TMS SA	--
DBV Technologies SA	--
Ascendis Pharma A/S	Upgrade
Akari Therapeutics Plc	Upgrade
Biodexa Pharmaceuticals Plc	--